Get the Stockscreener App
25.63
1.06%
0.2694
After Hours:
25.58
-0.054
-0.21%
Columbia Research Enhanced Value Etf Stock (REVS) Forecast
The Columbia Research Enhanced Value Etf (REVS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $26.40, representing a +2.99% increase from the current price of $25.63. The highest analyst price target is $27.10, and the lowest is $25.71.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month REVS Price Target
Average 27.59
(+7.62% Upside)
Is Columbia Research Enhanced Value Etf (REVS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 55.61 | Neutral |
| STOCH(9,6) | 18.15 | Buy |
| STOCHRSI(14) | 38.37 | Neutral |
| MACD(12,26) | 0.065 | Sell |
| ADX(14) | 16.82 | Neutral |
| William %R | -55.70 | Neutral |
| CCI(14) | -11.86 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
25.52
Buy
|
25.53
Buy
|
| MA20 |
25.64
Sell
|
25.52
Buy
|
| MA50 |
25.25
Buy
|
25.21
Buy
|
| MA100 |
24.52
Buy
|
24.66
Buy
|
| MA200 |
23.74
Buy
|
23.69
Buy
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, REVS could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 2 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on REVS, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 55.61 indicates that REVS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 18.15 indicates that REVS is oversold. This indicates that REVS price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 38.37 indicates that REVS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.82 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -11.86 indicates that REVS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term REVS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Columbia Research Enhanced Value Etf financial reports and earnings history, Columbia Research Enhanced Value Etf (REVS) stock could reach $47.53 by 2030, $95.17 by 2040 and $131.77 by 2050. See the projected annual prices until 2050 of the Columbia Research Enhanced Value Etf stock below:
- Columbia Research Enhanced Value Etf (REVS) is expected to reach an average price of $70.33 in 2035, with a high prediction of $70.44 and a low estimate of $68.98. This indicates an $174.35% rise from the last recorded price of $25.63.
- Columbia Research Enhanced Value Etf (REVS) stock is projected to chart a bullish course in 2040, with an average price target of $94.97, representing an $270.48% surge from its current level. The forecast ranges from a conservative $93.34 to a sky-high $95.17.
- Our analysts predict Columbia Research Enhanced Value Etf (REVS) to jump 318.97% by 2045, soaring from $106.66 to an average price of $107.40, potentially reaching $118.54. While $106.66 is the low estimate, the potential upside is significant.
- Columbia Research Enhanced Value Etf (REVS) stock is expected to climb by 2050, reaching an average of $131.74, a $413.93% jump from its current level. However, a wide range of estimates exists, with high and low targets of $131.77 and $129.47, respectively, highlighting the market's uncertainty.
Columbia Research Enhanced Value Etf Stock (REVS) Year by Year Forecast
Columbia Research Enhanced Value Etf Stock (REVS) Price Forecast for 2024
Our forecast for REVS stock price in 2024 now indicates an average price target of $24.16 with a high forecast of $27.10 and a low forecast of $21.22. The average prediction reflects an decrease of -5.76% from the last recorded price of $25.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $26.31 | $25.71 | $27.10 | +2.65% |
Columbia Research Enhanced Value Etf Stock (REVS) Price Forecast for 2025
Columbia Research Enhanced Value Etf Stock (REVS) is expected to reach an average price of $27.98 in 2025, with a high prediction of $31.00 and a low estimate of $24.96. This indicates an +9.15% rise from the last recorded price of $25.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $25.53 | $25.45 | $26.43 | -0.39% |
| February, 2025 | $25.97 | $24.96 | $26.09 | +1.33% |
| March, 2025 | $27.03 | $25.93 | $27.06 | +5.43% |
| April, 2025 | $27.63 | $26.83 | $28.07 | +7.78% |
| May, 2025 | $27.96 | $27.19 | $28.23 | +9.09% |
| June, 2025 | $28.69 | $27.79 | $28.80 | +11.92% |
| July, 2025 | $29.78 | $28.63 | $29.99 | +16.18% |
| August, 2025 | $29.11 | $28.85 | $30.22 | +13.55% |
| September, 2025 | $28.47 | $28.25 | $29.65 | +11.07% |
| October, 2025 | $28.95 | $27.79 | $29.10 | +12.92% |
| November, 2025 | $29.68 | $28.59 | $29.68 | +15.78% |
| December, 2025 | $30.51 | $29.73 | $31.00 | +19.00% |
Columbia Research Enhanced Value Etf Stock (REVS) Price Forecast for 2026
The predicted value for Columbia Research Enhanced Value Etf (REVS) in 2026 is set at an average of $33.32. Estimates vary from a peak of $36.47 to a trough of $30.17, indicating an +30.00% surge from the present price of $25.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $30.93 | $30.17 | $30.96 | +20.65% |
| February, 2026 | $31.31 | $30.83 | $31.45 | +22.15% |
| March, 2026 | $32.29 | $31.22 | $32.45 | +25.98% |
| April, 2026 | $32.34 | $32.23 | $33.35 | +26.15% |
| May, 2026 | $32.40 | $32.00 | $32.80 | +26.41% |
| June, 2026 | $30.64 | $30.62 | $31.92 | +19.53% |
| July, 2026 | $32.38 | $30.71 | $32.43 | +26.31% |
| August, 2026 | $33.72 | $32.32 | $33.93 | +31.54% |
| September, 2026 | $33.45 | $33.11 | $33.72 | +30.49% |
| October, 2026 | $34.11 | $33.48 | $34.25 | +33.06% |
| November, 2026 | $35.06 | $33.86 | $35.15 | +36.77% |
| December, 2026 | $36.14 | $35.06 | $36.47 | +41.00% |
Columbia Research Enhanced Value Etf Stock (REVS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Columbia Research Enhanced Value Etf (REVS) is $36.53, with a high forecast of $39.60 and a low forecast of $33.45. This indicates an +42.49% increase from the last price of $25.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $35.58 | $35.15 | $36.26 | +38.80% |
| February, 2027 | $34.00 | $33.85 | $35.86 | +32.63% |
| March, 2027 | $35.11 | $33.45 | $35.21 | +36.97% |
| April, 2027 | $35.84 | $35.09 | $35.85 | +39.82% |
| May, 2027 | $36.52 | $35.98 | $36.86 | +42.46% |
| June, 2027 | $37.14 | $36.14 | $37.26 | +44.87% |
| July, 2027 | $37.99 | $36.90 | $38.03 | +48.21% |
| August, 2027 | $39.09 | $38.06 | $39.30 | +52.51% |
| September, 2027 | $38.95 | $38.30 | $39.60 | +51.93% |
| October, 2027 | $37.12 | $36.65 | $39.10 | +44.82% |
| November, 2027 | $37.51 | $36.29 | $37.56 | +46.33% |
| December, 2027 | $38.66 | $37.19 | $38.69 | +50.82% |
Columbia Research Enhanced Value Etf Stock (REVS) Price Forecast for 2028
In 2028, Columbia Research Enhanced Value Etf (REVS) is projected to reach an average price of $41.64, with a high projection of $44.78 and a low estimate of $38.51. This indicates an +62.45% rise from the last price of $25.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $39.36 | $38.51 | $39.79 | +53.55% |
| February, 2028 | $39.91 | $39.13 | $39.94 | +55.70% |
| March, 2028 | $40.89 | $39.93 | $41.00 | +59.51% |
| April, 2028 | $41.66 | $40.87 | $41.94 | +62.51% |
| May, 2028 | $41.70 | $41.44 | $42.72 | +62.67% |
| June, 2028 | $39.67 | $39.45 | $42.28 | +54.76% |
| July, 2028 | $39.51 | $39.12 | $40.38 | +54.11% |
| August, 2028 | $41.27 | $39.64 | $41.27 | +61.00% |
| September, 2028 | $42.16 | $41.36 | $42.72 | +64.49% |
| October, 2028 | $42.40 | $42.11 | $42.64 | +65.42% |
| November, 2028 | $43.47 | $42.47 | $43.60 | +69.57% |
| December, 2028 | $44.62 | $43.42 | $44.78 | +74.08% |
Columbia Research Enhanced Value Etf Stock (REVS) Price Forecast for 2029
The 2029 price forecast for Columbia Research Enhanced Value Etf Stock (REVS) is $45.46 on average, with a high prediction of $48.98 and a low estimate of $41.95. This represents an +77.36% increase from the previous price of $25.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $44.88 | $44.60 | $45.85 | +75.09% |
| February, 2029 | $45.02 | $44.59 | $45.44 | +75.62% |
| March, 2029 | $41.97 | $41.95 | $43.21 | +63.73% |
| April, 2029 | $43.74 | $42.09 | $43.83 | +70.63% |
| May, 2029 | $45.44 | $43.75 | $45.65 | +77.26% |
| June, 2029 | $45.44 | $44.87 | $45.62 | +77.26% |
| July, 2029 | $46.19 | $45.10 | $46.31 | +80.18% |
| August, 2029 | $47.35 | $45.98 | $47.43 | +84.70% |
| September, 2029 | $48.89 | $47.39 | $48.90 | +90.73% |
| October, 2029 | $48.26 | $47.74 | $48.98 | +88.25% |
| November, 2029 | $45.29 | $45.05 | $48.58 | +76.67% |
| December, 2029 | $46.03 | $44.78 | $46.11 | +79.57% |
Columbia Research Enhanced Value Etf Stock (REVS) Price Forecast for 2030
Columbia Research Enhanced Value Etf Stock (REVS) is expected to reach an average price of $49.39 in 2030, with a high forecast of $52.72 and a low forecast of $46.07. This signifies an +92.68% surge from the last price of $25.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $47.52 | $46.07 | $47.53 | +85.38% |
| February, 2030 | $48.37 | $47.70 | $48.58 | +88.69% |
| March, 2030 | $49.01 | $48.08 | $49.28 | +91.18% |
| April, 2030 | $50.04 | $49.01 | $50.15 | +95.20% |
| May, 2030 | $51.51 | $50.06 | $51.72 | +100.95% |
| June, 2030 | $51.14 | $50.89 | $52.10 | +99.50% |
| July, 2030 | $48.37 | $47.85 | $51.78 | +88.68% |
| August, 2030 | $48.93 | $47.62 | $48.93 | +90.87% |
| September, 2030 | $49.96 | $48.65 | $49.96 | +94.91% |
| October, 2030 | $51.17 | $50.09 | $51.51 | +99.62% |
| November, 2030 | $51.90 | $51.07 | $51.92 | +102.45% |
| December, 2030 | $52.58 | $51.95 | $52.72 | +105.13% |
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):